Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001062993-23-002792)

Filing Details

Accession Number:: 0001062993-23-002792
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-02-10 21:48:31
Reporting Period:: 2023-02-08

Accepted Time:: 2023-02-10 21:48:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
886744	Geron Corp	GERN	Pharmaceutical Preparations (2834)	752287752

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1501545	Kyusuk Olivia Bloom	C/O Geron Corporation 919 E. Hillsdale Blvd, Suite 250 Foster City CA 94404	Evp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-02-08	400,000	$1.51	474,588	No	4	M	Direct
Common Stock	Disposition	2023-02-08	400,000	$3.08	74,588	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2023-02-08	400,000	$0.00	400,000	$1.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2023-02-12	No	4	M	Direct

Footnotes

Option was fully vested.
This transaction reflects an exercise and sale of options due to expire on February 12, 2023 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023.